Clinical Trial

Efficacy and Effectiveness of an Investigational Behind-the-Ear Hearing Device Kit

Completed
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn if Sonova's rechargeable behind-the-ear hearing device kit works to treat hearing loss in adults. The main questions it aims to answer are: * Does the rechargeable behind-the-ear hearing device kit address challenging listening situations identified by participants while providing a satisfactory user experience? * Does the rechargeable behind-the-ear hearing device kit improve speech understanding in noise in a lab setting? Researchers will compare participants' performance with the rechargeable behind-the-ear hearing device kit to the unaided condition to see if it works to treat hearing loss. The rechargeable behind-the-ear hearing device kit will be subjectively compared to their personal hearing device experience. Participants will: * Use the rechargeable behind-the-ear hearing device kit for approximately 2 weeks. * Visit the clinic for the initial fitting and follow-up testing at the end of the study. Additional study visits may take place, as needed. * Complete questionnaires to identify challenging listening situations and provide feedback on their experience with the devices. * Complete lab testing to assess speech intelligibility in the presence of background noise and provide subjective feedback on features in the Mobile application.
Protocol Amendment History 1 change
critical Trial completed 2026-08-12
Trial Details
NCT Number NCT07414329
Lead Sponsor Sonova AG
Collaborators: National Hearing Services Inc
Conditions Hearing Loss
Enrollment 20 participants
Start Date 2026-01-30
Primary Completion 2026-03-18 (estimated)
Study Completion 2026-03-18 (estimated)
Updated on ClinicalTrials.gov 2026-08-11